NCT03174145View on ClinicalTrials.gov

Validation Study to Investigate the Effect of a New Treatment in Patients With Osteoarthritic Pain

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

August 24, 2018

Study Completion Date

August 24, 2018

Conditions
Osteoarthritis
Interventions
BEHAVIORAL

Positive behaviour

Information about T4P1010 treatment

DRUG

T4P1010 administration

Provide treatment to be taken twice a day between Visit 2 and Visit 5 as add-on therapy to patient's regular analgesic treatment

GENETIC

Pharmacogenetic

Blood sample of 10 millilitres maximum

OTHER

Questionnaires and diary completion

Personality, pain and disease questionnaires completion during the study Diary completion between Visit 1 and Visit 5

Trial Locations (6)

4000

CHU Liège, Médecine de l'appareil locomoteur, Liège

38610

Eurofins Optimed, Gières

75012

Hopital Saint Antoine AP-HP Rhumatologie, Paris

75014

Hopital Cochin AP-HP Evaluation et traitement de la Douleur, Paris

WS11 0BN

Mac Clinical Research, Cannock

L34 1BH

Mac Clinical Research, Liverpool

All Listed Sponsors
lead

Tools4Patient

OTHER

NCT03174145 - Validation Study to Investigate the Effect of a New Treatment in Patients With Osteoarthritic Pain | Biotech Hunter | Biotech Hunter